CRSP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $313,950.00

Insider Selling (Last 12 Months): $4,541,220.72

CRISPR Therapeutics Insider Trading History Chart

CRISPR Therapeutics Share Price & Price History

^$37.40

▼ -0.48 (-1.27%)

As of 04/29/2025 05:00 PM ET

Days: 30 | 90 | 365

CRISPR Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2025	James R Kasinger	General Counsel	Sell	2,850	$42.42	$120,897.00	77,530
3/11/2025	Julianne Bruno	COO	Sell	1,198	$42.42	$50,819.16	8,263
3/11/2025	Samarth Kulkarni	CEO	Sell	9,973	$42.42	$423,054.66	180,890
2/26/2025	John Greene	Director	Buy	7,000	$44.85	$313,950.00	7,000
2/19/2025	Samarth Kulkarni	CEO	Sell	18,360	$55.20	$1,013,472.00	171,613
12/2/2024	Samarth Kulkarni	CEO	Sell	15,000	$55.10	$826,500.00	181,540
11/11/2024	Samarth Kulkarni	CEO	Sell	30,000	$55.62	$1,668,600.00	196,540
10/14/2024	James R Kasinger	General Counsel	Sell	1,089	$46.28	$50,398.92	62,597
10/14/2024	Samarth Kulkarni	CEO	Sell	4,293	$46.28	$198,680.04	226,540
6/21/2024	Julianne Bruno	COO	Sell	3,366	$56.09	$188,798.94	6,745
4/15/2024	Samarth Kulkarni	CEO	Sell	19,582	$59.91	$1,173,157.62	208,122
3/15/2024	Raju Prasad	CFO	Sell	3,524	$72.69	$256,159.56	6,476
3/15/2024	Samarth Kulkarni	CEO	Sell	20,000	$72.48	$1,449,600.00	208,122
3/11/2024	James R Kasinger	General Counsel	Sell	2,801	$78.26	$219,206.26	60,070
3/11/2024	Samarth Kulkarni	CEO	Sell	9,802	$78.26	$767,104.52	203,705
2/20/2024	James R Kasinger	General Counsel	Sell	1,913	$79.67	$152,408.71	57,371
2/20/2024	Samarth Kulkarni	CEO	Sell	6,370	$79.67	$507,497.90	194,257
2/15/2024	Samarth Kulkarni	CEO	Sell	20,000	$80.36	$1,607,200.00	187,377
1/29/2024	Samarth Kulkarni	CEO	Sell	50,000	$60.51	$3,025,500.00	187,377
1/16/2024	Samarth Kulkarni	CEO	Sell	20,000	$62.50	$1,250,000.00	187,377
5/30/2023	Samarth Kulkarni	CEO	Sell	25,000	$64.88	$1,622,000.00	387,377
4/25/2023	Samarth Kulkarni	CEO	Sell	25,000	$50.67	$1,266,750.00	387,377
3/29/2023	Samarth Kulkarni	CEO	Sell	25,000	$44.46	$1,111,500.00	387,377
2/27/2023	Samarth Kulkarni	CEO	Sell	25,000	$48.25	$1,206,250.00	375,988
1/27/2023	Samarth Kulkarni	CEO	Sell	25,000	$51.47	$1,286,750.00	369,111
12/28/2022	Samarth Kulkarni	CEO	Sell	25,000	$40.93	$1,023,250.00	369,111
11/28/2022	Samarth Kulkarni	CEO	Sell	25,000	$54.03	$1,350,750.00	290,279
10/26/2022	Samarth Kulkarni	CEO	Sell	25,000	$54.81	$1,370,250.00	290,279
9/28/2022	Samarth Kulkarni	CEO	Sell	25,000	$64.61	$1,615,250.00	290,279
8/29/2022	Samarth Kulkarni	CEO	Sell	25,000	$66.84	$1,671,000.00	290,279
7/27/2022	Samarth Kulkarni	CEO	Sell	25,000	$75.91	$1,897,750.00	290,279
6/29/2022	Samarth Kulkarni	CEO	Sell	25,000	$61.59	$1,539,750.00	290,279

See Full Table

SEC Filings (Institutional Ownership Changes) for CRISPR Therapeutics (NASDAQ:CRSP)

69.20% of CRISPR Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

CRISPR Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/29/2025	Capital Advisors Inc. OK	307,498	$10.46M	0.2%	-0.9%	0.356%
4/29/2025	Envestnet Asset Management Inc.	68,058	$2.32M	0.0%	+21.5%	0.079%
4/29/2025	Bank of New York Mellon Corp	77,702	$2.64M	0.0%	+1.5%	0.090%
4/29/2025	GF Fund Management CO. LTD.	2,186	$74K	0.0%	+22.0%	0.003%
4/28/2025	Teacher Retirement System of Texas	21,823	$0.74M	0.0%	-9.0%	0.025%
4/28/2025	Vontobel Holding Ltd.	12,741	$0.43M	0.0%	-15.4%	0.015%
4/25/2025	Westside Investment Management Inc.	7,942	$0.27M	0.1%	+29.1%	0.009%
4/25/2025	KBC Group NV	3,750	$0.13M	0.0%	-93.8%	0.004%
4/25/2025	Sumitomo Mitsui Trust Group Inc.	2,539,889	$86.43M	0.1%	-7.5%	2.941%
4/24/2025	Hedges Asset Management LLC	29,350	$1M	0.6%	+20.5%	0.034%
4/23/2025	Tyche Wealth Partners LLC	9,185	$0.31M	0.1%	+10.2%	0.011%
4/23/2025	Spire Wealth Management	1,670	$57K	0.0%	-15.2%	0.002%
4/23/2025	Oppenheimer & Co. Inc.	9,474	$0.32M	0.0%	-17.5%	0.011%
4/22/2025	Cambridge Investment Research Advisors Inc.	39,189	$1.33M	0.0%	+14.3%	0.046%
4/17/2025	Mason & Associates Inc	5,900	$0.20M	0.0%	N/A	0.007%
4/17/2025	Sowell Financial Services LLC	11,554	$0.39M	0.0%	+8.4%	0.013%
4/17/2025	Janney Montgomery Scott LLC	10,703	$0.36M	0.0%	+55.7%	0.012%
4/16/2025	Wealth Enhancement Advisory Services LLC	94,100	$3.20M	0.0%	+244.5%	0.110%
4/16/2025	Ipswich Investment Management Co. Inc.	24,543	$0.84M	0.2%	-2.9%	0.029%
4/15/2025	Handelsbanken Fonder AB	23,900	$0.81M	0.0%	-2.0%	0.028%
4/15/2025	SG Americas Securities LLC	29,341	$1M	0.0%	+39.1%	0.034%
4/15/2025	Avanza Fonder AB	25,341	$0.87M	0.0%	N/A	0.030%
4/14/2025	Farther Finance Advisors LLC	5,626	$0.19M	0.0%	+46.7%	0.007%
4/11/2025	Congress Asset Management Co.	68,302	$2.32M	0.0%	-0.6%	0.080%
4/10/2025	Hennion & Walsh Asset Management Inc.	39,957	$1.36M	0.1%	-9.8%	0.047%
4/9/2025	Harbor Investment Advisory LLC	3,755	$0.13M	0.0%	-15.7%	0.004%
4/9/2025	NBC Securities Inc.	1,564	$53K	0.0%	+156,300.0%	0.002%
4/9/2025	Green Alpha Advisors LLC	57,361	$1.95M	2.1%	+132.9%	0.067%
4/9/2025	180 Wealth Advisors LLC	6,349	$0.22M	0.0%	+22.9%	0.007%
4/7/2025	GAMMA Investing LLC	4,288	$0.15M	0.0%	+8,146.2%	0.005%
4/7/2025	AdvisorNet Financial Inc	5,073	$0.17M	0.0%	+104.7%	0.006%
4/4/2025	Capital Market Strategies LLC	21,367	$0.73M	0.5%	+82.4%	0.025%
3/18/2025	California State Teachers Retirement System	69,742	$2.75M	0.0%	-1.0%	0.081%
3/17/2025	Wealth Enhancement Advisory Services LLC	27,311	$1.08M	0.0%	-9.7%	0.032%
3/6/2025	Wood Tarver Financial Group LLC	775	$30K	0.0%	N/A	0.001%
2/24/2025	Ameriflex Group Inc.	855	$36K	0.0%	N/A	0.001%
2/19/2025	GF Fund Management CO. LTD.	1,792	$71K	0.0%	N/A	0.002%
2/18/2025	Sunbelt Securities Inc.	6,165	$0.24M	0.0%	+108.6%	0.007%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	690,191	$27.17M	0.0%	+2.1%	0.809%
2/17/2025	Voloridge Investment Management LLC	52,835	$2.08M	0.0%	-68.2%	0.062%
2/17/2025	Waverly Advisors LLC	15,495	$0.61M	0.0%	-20.1%	0.018%
2/17/2025	Woodline Partners LP	101,600	$4M	0.0%	+1.6%	0.119%
2/17/2025	Westwood Holdings Group Inc.	53,102	$2.09M	0.0%	+18.1%	0.062%
2/17/2025	Two Sigma Advisers LP	84,800	$3.34M	0.0%	+50.4%	0.099%
2/17/2025	Two Sigma Investments LP	306,272	$12.06M	0.0%	+71.1%	0.359%
2/17/2025	Rafferty Asset Management LLC	165,816	$6.53M	0.0%	-22.5%	0.194%
2/17/2025	Main Management ETF Advisors LLC	13,528	$0.53M	0.0%	-8.2%	0.016%
2/17/2025	Millennium Management LLC	8,498	$0.33M	0.0%	-94.1%	0.010%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	79,967	$3.14M	0.0%	+21.5%	0.094%
2/17/2025	Lazard Asset Management LLC	71,023	$2.80M	0.0%	-16.7%	0.083%
2/17/2025	Focus Partners Wealth	5,542	$0.24M	0.0%	N/A	0.006%
2/17/2025	Deutsche Bank AG	8,133	$0.32M	0.0%	+65.0%	0.010%
2/17/2025	Cresset Asset Management LLC	15,042	$0.59M	0.0%	-44.5%	0.018%
2/17/2025	Cetera Investment Advisers	29,835	$1.17M	0.0%	-16.2%	0.035%
2/17/2025	Bridgefront Capital LLC	17,264	$0.68M	0.2%	N/A	0.020%
2/17/2025	Captrust Financial Advisors	28,570	$1.13M	0.0%	-9.9%	0.033%
2/17/2025	Baker BROS. Advisors LP	1,308,011	$51.48M	0.5%	+55.1%	1.533%
2/17/2025	Bank of America Corp DE	1,211,509	$47.69M	0.0%	+12.0%	1.419%
2/17/2025	Benjamin Edwards Inc.	45,062	$1.77M	0.0%	+37.8%	0.053%
2/17/2025	BNP Paribas Financial Markets	82,994	$3.27M	0.0%	-5.6%	0.097%
2/17/2025	Ameriprise Financial Inc.	205,173	$8.07M	0.0%	+9.9%	0.240%
2/17/2025	Alteri Wealth LLC	5,525	$0.22M	0.1%	N/A	0.006%
2/17/2025	Ancora Advisors LLC	2,930	$0.12M	0.0%	-26.8%	0.003%
2/17/2025	Aptus Capital Advisors LLC	6,298	$0.25M	0.0%	N/A	0.007%
2/14/2025	Mercer Global Advisors Inc. ADV	9,980	$0.39M	0.0%	-13.8%	0.012%
2/14/2025	Northern Trust Corp	257,168	$10.12M	0.0%	+12.9%	0.301%
2/14/2025	Aquatic Capital Management LLC	47,644	$1.88M	0.1%	-8.9%	0.056%
2/14/2025	Susquehanna Fundamental Investments LLC	92,387	$3.64M	0.1%	N/A	0.108%
2/14/2025	Virtus ETF Advisers LLC	7,702	$0.30M	0.1%	+52.6%	0.009%
2/14/2025	T. Rowe Price Investment Management Inc.	3,811,708	$150.03M	0.1%	+39.2%	4.466%
2/14/2025	Price T Rowe Associates Inc. MD	24,563	$0.97M	0.0%	+3.4%	0.029%
2/14/2025	Hsbc Holdings PLC	17,496	$0.69M	0.0%	+16.1%	0.020%
2/14/2025	Stifel Financial Corp	43,128	$1.70M	0.0%	+7.2%	0.051%
2/14/2025	TD Waterhouse Canada Inc.	1,043	$41K	0.0%	-20.4%	0.001%
2/14/2025	Tower Research Capital LLC TRC	5,453	$0.22M	0.0%	+499.9%	0.006%
2/14/2025	Capital International Inc. CA	99,292	$3.91M	0.0%	-3.2%	0.116%
2/14/2025	Curi RMB Capital LLC	49,061	$1.93M	0.0%	+5.0%	0.057%
2/14/2025	Dimensional Fund Advisors LP	947,301	$37.28M	0.0%	+14.9%	1.110%
2/14/2025	Freedom Investment Management Inc.	10,017	$0.39M	0.0%	+22.7%	0.012%
2/14/2025	Capital International Ltd. CA	128,380	$5.05M	0.2%	+2.2%	0.150%
2/14/2025	Capital Group Investment Management PTE. LTD.	27,698	$1.09M	0.2%	+2.1%	0.032%
2/14/2025	Capital International Investors	8,743,523	$344.15M	0.1%	+10.3%	10.244%
2/14/2025	Capital International Sarl	186,920	$7.36M	0.2%	+9.6%	0.219%
2/13/2025	NewEdge Advisors LLC	7,420	$0.29M	0.0%	+28.0%	0.009%
2/13/2025	Jump Financial LLC	139,280	$5.48M	0.1%	+174.0%	0.163%
2/13/2025	Guggenheim Capital LLC	87,201	$3.43M	0.0%	-0.8%	0.102%
2/13/2025	Elkhorn Partners Limited Partnership	3,800	$0.15M	0.1%	+22.6%	0.004%
2/13/2025	XTX Topco Ltd	8,919	$0.35M	0.0%	-70.3%	0.010%
2/13/2025	Mariner LLC	5,765	$0.23M	0.0%	-11.5%	0.007%
2/13/2025	Barclays PLC	102,058	$4.02M	0.0%	-21.4%	0.120%
2/13/2025	Reynders McVeigh Capital Management LLC	97,687	$3.85M	0.2%	-18.3%	0.114%
2/13/2025	Rockefeller Capital Management L.P.	89,572	$3.53M	0.0%	-3.5%	0.105%
2/13/2025	Jaffetilchin Investment Partners LLC	5,208	$0.21M	0.0%	+56.9%	0.006%
2/13/2025	Scotia Capital Inc.	12,295	$0.48M	0.0%	+11.8%	0.014%
2/13/2025	Raymond James Financial Inc.	82,095	$3.23M	0.0%	N/A	0.096%
2/13/2025	Advisory Services Network LLC	10,057	$0.40M	0.0%	-43.1%	0.012%
2/13/2025	Legal & General Group Plc	97,804	$3.85M	0.0%	-8.5%	0.115%
2/13/2025	Invesco Ltd.	33,790	$1.33M	0.0%	+6.3%	0.040%
2/13/2025	Himension Capital Singapore PTE. LTD.	80,770	$3.18M	0.2%	-0.5%	0.095%
2/13/2025	Envestnet Asset Management Inc.	56,033	$2.21M	0.0%	+2.3%	0.066%

Data available starting January 2016

See Full Table

CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

Today's Range

Now: $37.40

$37.24

$38.29

50 Day Range

MA: $39.72

$31.27

$50.46

52 Week Range

Now: $37.40

$30.04

$67.88

Volume

1,257,101 shs

Average Volume

1,640,212 shs

Market Capitalization

$3.23 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.85

Who are the company insiders with the largest holdings of CRISPR Therapeutics?: CRISPR Therapeutics' top insider shareholders include:
Samarth Kulkarni (CEO)
James R Kasinger (General Counsel)
Julianne Bruno (COO)
John Greene (Director)
Raju Prasad (CFO)
Learn More about top insider investors at CRISPR Therapeutics.
Who are the major institutional investors of CRISPR Therapeutics?: CRISPR Therapeutics' top institutional shareholders include:
Sumitomo Mitsui Trust Group Inc. — 2.94%
IMC Chicago LLC — 0.00%
Wealth Enhancement Advisory Services LLC — 0.11%
Congress Asset Management Co. — 0.08%
Green Alpha Advisors LLC — 0.07%
Hennion & Walsh Asset Management Inc. — 0.05%
Learn More about top institutional investors of CRISPR Therapeutics stock.
Which institutional investors are selling CRISPR Therapeutics stock?: During the previous quarter, CRSP stock was sold by these institutional investors:
Sumitomo Mitsui Trust Group Inc.
KBC Group NV
Hennion & Walsh Asset Management Inc.
Vontobel Holding Ltd.
Teacher Retirement System of Texas
Oppenheimer & Co. Inc.
Ipswich Investment Management Co. Inc.
Harbor Investment Advisory LLC
In the last year, company insiders that have sold CRISPR Therapeutics company stock include:
Samarth Kulkarni (CEO)
James R Kasinger (General Counsel)
Julianne Bruno (COO)
Learn More investors selling CRISPR Therapeutics stock.
Which institutional investors are buying CRISPR Therapeutics stock?: During the previous quarter, CRSP stock was acquired by institutional investors including:
Wealth Enhancement Advisory Services LLC
Green Alpha Advisors LLC
Avanza Fonder AB
Capital Market Strategies LLC
SG Americas Securities LLC
IMC Chicago LLC
Mason & Associates Inc
Hedges Asset Management LLC